Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Inhibrx Biosciences, Inc.
About INBX
Inhibrx Biosciences, Inc. is a clinical-stage biopharmaceutical company focused on developing a broad pipeline of novel biologic therapeutic candidates. The Company utilizes diverse methods of protein engineering to address the specific requirements of complex target and disease biology, including its proprietary protein engineering platforms. Its clinical pipeline of therapeutic candidates includes ozekibart (INBRX-109) and INBRX-106. INBRX-109 is an engineered tetravalent single domain antibody (sdAb)-based therapeutic candidate that agonizes DR5 to induce tumor selective programmed cell death. INBRX-106 is a hexavalent sdAb-based therapeutic candidate targeting OX40 that provides co-stimulation that promotes T-cell expansion, enhanced effector function and memory cell formation, and prevents activation-induced cell death. INBRX-106 in Combination with Pembrolizumab in Patients with Locally Advanced or Metastatic Solid Tumors.
Find out what a historical investment in Inhibrx Biosciences, Inc. would be worth today using our INBX stock calculator.
Market Capitalisation
$1.35B
Price-earnings ratio
-
Dividend yield
0.00%
Volume
263.34K
High today
$95.26
Low today
$88.63
Open price
$88.63
52-week high
$155.29
52-week low
$13.92
Ready to start your investing journey with Stake?
Open an accountHow do I buy INBX shares in Australia?
Buying INBX shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Inhibrx Biosciences, Inc. in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in INBX
What is the ticker symbol of Inhibrx Biosciences, Inc. ?
The ticker symbol for Inhibrx Biosciences, Inc. is INBX.
How much is one share of INBX?
One share of INBX is valued at $0.00 as of 13 June 2026.
What is the market capitalisation of Inhibrx Biosciences, Inc. INBX?
As of 13 June 2026 Inhibrx Biosciences, Inc. has a market cap of $1.35B.
What is the 52-week high for Inhibrx Biosciences, Inc. stock?
The Inhibrx Biosciences, Inc. 52-week high stock price is $155.29.
What is the 52-week low for Inhibrx Biosciences, Inc. stock?
The Inhibrx Biosciences, Inc. 52-week low stock price is $13.92.
Can I buy INBX shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy INBX shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in INBX on Stake
- Buy INBX from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of INBX from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
INBX related stocks